SCHEMBL5722453

SCHEMBL5722453

CC(=O)NC[C@@H]1C[C@H](C(=O)OC(C)(C)C)C[C@H]1N

nearest known ligand 0.44

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.32
▸ BTK Q06187 1/20 0.32
▸ CACNA1H O95180 1/20 0.32
▸ HRH3 Q9Y5N1 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722384 0.82 SLC6A12 (0.34) BTKHRH3
SCHEMBL5722385 0.80 SLC6A12 (0.39) —
SCHEMBL17249604 0.79 — —
SCHEMBL31368028 0.73 MAPK1 (0.37) BTKHRH3
Hydrochloric Acid SCHEMBL31368151 0.72 MAPK1 (0.36) BTKHRH3
SCHEMBL17883938 0.70 HRH3 (0.39) KMT2ABTKHRH3
SCHEMBL3405894 0.70 HRH3 (0.39) KMT2ABTKHRH3
SCHEMBL17883906 0.70 HRH3 (0.39) KMT2ABTKHRH3
SCHEMBL6560716 0.70 HRH3 (0.35) KMT2ABTKHRH3
SCHEMBL1298062 0.70 HRH3 (0.43) KMT2ABTKHRH3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0933993-B1 SUBSTITUTED CYCLOPENTANE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS BIOCRYST PHARM INC (US) 2006-04-05 — — EP disclosed
US-6410594-B1 VIRICIDES BIOCRYST PHARMACEUTICALS, INC. 2002-06-25 — — US disclosed
Send feedback